{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:08:37Z","timestamp":1783962517748,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.mvr.2026.104954","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T07:38:11Z","timestamp":1776065891000},"page":"104954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Angiogenic and intraplatelet growth biomarkers in systemic sclerosis"],"prefix":"10.1016","volume":"166","author":[{"given":"Bryan Josu\u00e9","family":"Flores Robles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"G\u00f3mez Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Bueno Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"N\u00fa\u00f1ez Mart\u00edn-Buitrago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Mulero Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman Alberto","family":"Salazar Asencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegarda","family":"Godoy Tundidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Rusinovich Lovgach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Martos Gisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Andr\u00e9u S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-6744","authenticated-orcid":false,"given":"Alejandra","family":"S\u00e1nchez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mvr.2026.104954_bb0005","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/ijms19051269","article-title":"VEGF (Vascular Endothelial Growth Factor) and fibrotic lung disease","volume":"19","author":"Barratt","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mvr.2026.104954_bb0010","first-page":"3","article-title":"G-CSF: function and modes of action (review)","volume":"10","author":"Basu","year":"2002","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.mvr.2026.104954_bb0015","first-page":"4123","article-title":"VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is downregulated in renal cell carcinoma","volume":"62","author":"Bates","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.mvr.2026.104954_bb0025","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1537-2995.2005.00215.x","article-title":"A randomized crossover trial comparing three plateletpheresis machines","volume":"45","author":"Bueno","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.mvr.2026.104954_bb0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.autrev.2014.12.001","article-title":"Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis","volume":"14","author":"Chora","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.mvr.2026.104954_bb0035","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3899\/jrheum.160791","article-title":"Evidence for derangement of the microvascular systemic patients with a very early diagnosis of systemic sclerosis","volume":"44","author":"Chora","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.mvr.2026.104954_bb0040","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/rheumatology\/keh156","article-title":"Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis","volume":"43","author":"Cutolo","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.mvr.2026.104954_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13317-016-0077-y","article-title":"Naildfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement","volume":"7","author":"De Santis","year":"2016","journal-title":"Auto immun Highlights."},{"key":"10.1016\/j.mvr.2026.104954_bb0050","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","article-title":"Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers","volume":"4","author":"Distler","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.mvr.2026.104954_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2017.09.003","article-title":"Fibroblast growth factor 2 as antifibrotic: antagonism of myofibroblast differentiation and suppression of pro-fibrotic gene expression","volume":"38","author":"Dolivo","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.mvr.2026.104954_bb0060","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma (mechanisms of the disease)","volume":"360","author":"Gabrielli","year":"2009","journal-title":"NEJM"},{"key":"10.1016\/j.mvr.2026.104954_bb0065","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/rheumatology\/38.7.612","article-title":"Enhanced production of IL-6, Oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis","volume":"38","author":"Hasegawa","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.mvr.2026.104954_bb0070","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13075-015-0848-2","article-title":"Inhibition of angiogenesis by platelets in systemic sclerosis system","volume":"17","author":"Hirigoyen","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.mvr.2026.104954_bb0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0625.2010.01082.x","article-title":"Scleroderma: from pathophysiology to novel therapeutic approaches","volume":"19","author":"Hunzelmann","year":"2010","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.mvr.2026.104954_bb0080","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10067-016-3483-7","article-title":"Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patient with systemic sclerosis","volume":"36","author":"Ilgen","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.mvr.2026.104954_bb0085","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/s10165-012-0787-6","article-title":"Upregulation of VEGF expression is associated with accumulation of HIF-1\u03b1 in the skin of naive scleroderma patients","volume":"23","author":"Ioannou","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.mvr.2026.104954_bb0090","series-title":"Platelets","first-page":"21","article-title":"Megakaryocyte development and platelet formation","author":"Italino","year":"2002"},{"key":"10.1016\/j.mvr.2026.104954_bb0095","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0190-9622(96)90603-9","article-title":"Serum concentrations of basic FGF-2 in collagen diseases","volume":"35","author":"Kadono","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.mvr.2026.104954_bb0020","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis","volume":"15","author":"Le Roy","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.mvr.2026.104954_bb0100","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.mvr.2026.104954_bb0105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1346-8138.12011","article-title":"Serum levels of interleukin 1-alpha with systemic sclerosis","volume":"40","author":"Maekawa","year":"2013","journal-title":"J. Dermatol."},{"key":"10.1016\/j.mvr.2026.104954_bb0110","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.mvr.2026.104954_bb0115","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/art.1780240907","article-title":"Wide field capillary microscopy","volume":"24","author":"Maricq","year":"1981","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.mvr.2026.104954_bb0120","first-page":"275","article-title":"Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin elevation with spontaneous regression of skin sclerosis","volume":"33","author":"Matsushita","year":"2006","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.mvr.2026.104954_bb0125","first-page":"104","article-title":"Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis","volume":"34","author":"Meyer","year":"2007","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.mvr.2026.104954_bb0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11926-007-0013-2","article-title":"Current concepts in normal and defective angiogenesis: implication for systemic sclerosis","volume":"9","author":"Mulligan-Keho","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.mvr.2026.104954_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","article-title":"Interlukin-1, Interlukin-2, Interlukin-4, Interleukin-6, TNF alpha, Interferon gamma levels in sera from patients with scleroderma","volume":"35","author":"Needleman","year":"1992","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.mvr.2026.104954_bb0140","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/cea.14192","article-title":"A method based on plateletpheresis to obtain functional platelet, CD3+ and CD14+ matched populations for research immunological studies","volume":"52","author":"Pablo-Torres","year":"2022","journal-title":"Clin. Exp. Allergy"},{"issue":"11","key":"10.1016\/j.mvr.2026.104954_bb0145","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","article-title":"Biology and therapeutic targeting of vascular endothelial growth factor A","volume":"24","author":"P\u00e9rez-Guti\u00e9rrez","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mvr.2026.104954_bb0150","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/BOR.0b013e3282eeb3a4","article-title":"Platelet contribution to the pathogenesis of systemic sclerosis","volume":"19","author":"Postlethwaite","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.mvr.2026.104954_bb0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archderm.1993.01680230073008","article-title":"Demostration of interleukin 8 and autoantibodies to inteleukin-8 in the serum of patients with systemic sclerosis and related disorders","volume":"129","author":"Reitamo","year":"1993","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.mvr.2026.104954_bb0160","article-title":"The anti-scar effects of basic fibroblast growth factor on the wound repair in vitro and in vivo","volume":"8","author":"Shi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mvr.2026.104954_bb0165","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.22328","article-title":"Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma","volume":"56","author":"Sonnylal","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.mvr.2026.104954_bb0170","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF00371783","article-title":"Response of scleroderma fibroblasts to various growth factors","volume":"283","author":"Takehara","year":"1991","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.mvr.2026.104954_bb0175","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototype multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mvr.2026.104954_bb0180","doi-asserted-by":"crossref","first-page":"7822","DOI":"10.1158\/0008-5472.CAN-04-0934","article-title":"VEGF165b, an inhibitory vascular endothelial growth factor splice variant: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression","volume":"64","author":"Woolard","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.mvr.2026.104954_bb0185","first-page":"S110","article-title":"The relationship between biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations","volume":"34","author":"Yal\u00e7inkaya","year":"2016","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286226000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286226000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:42:57Z","timestamp":1783960977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286226000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S0026286226000543"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2026.104954","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiogenic and intraplatelet growth biomarkers in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2026.104954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104954"}}